The Molecular Diagnostics Market is expected to expand significantly
- Get link
- X
- Other Apps
Molecular diagnostic tests are used to detect differences in certain DNA or RNA sequences that may be linked to disease. Various disorders are caused by a disruption in the relationship between a single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and other factors. Infectious disorders, cancer, virology, and STDs are among the diseases that can be diagnosed with molecular diagnostic tests.
Molecular diagnostics can diagnose
specific diseases, which aids in giving patients with precision medicine. The
government of various economies is focusing on precision medicine research and
development, which is projected to propel the molecular
diagnostics market forward over the forecast period. For example, the
US government sponsored the Precision Medicine Initiative (PMI) in 2015 to
raise awareness of advances in precision medicine.
Molecular Diagnostics Market |
COVID-19 Impact on Global Molecular
Diagnostics Market
COVID-19, which was mostly unknown
until the outbreak in Wuhan, China, in December 2019, has gone from a regional
issue to a global pandemic in just a few weeks. The COVID-19 pandemic had a
negative impact on most companies' total sales, but it had a favourable influence
on the molecular
diagnostics market due to the increased usage of molecular diagnostic
technologies for COVID-19 testing. However, as governments increasingly loosen
travel restrictions, there is a rebound in testing numbers.With the COVID-19
pandemic, dealing with infectious disease has become a major medical concern
around the world. Aside from vaccinations and therapeutic medications, there is
an increasing demand for the development of more precise and simple testing
methods, as well as the expansion of testing structures. As governments and
healthcare providers face unprecedented problems, COVID-19 has had an impact on
the regulatory environment and practises. Regulatory agencies used a variety of
techniques to expedite the approval of diagnostic products. Companies have made
strategic decisions to implement COVID-19 rapid tests, maintain revenue, and
mitigate COVID-19's impact on their operating capabilities.
Regional insights
The greatest share of the worldwide
molecular diagnostics market is held by North America, which may be due to
rising use of precision medicine and rising cancer prevalence. According to the
National Cancer Institute, 16.8 million new instances of cancer were diagnosed
in the United States in 2016, with 595,690 people dying from the disease.
- Get link
- X
- Other Apps
Comments
Post a Comment